These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9052990)

  • 1. Malignant transformation induced by cytokine genes: a comparison of the abilities of germline and mutated interleukin 3 genes to transform hematopoietic cells by transcriptional and posttranscriptional mechanisms.
    Wang XY; McCubrey JA
    Cell Growth Differ; 1996 Apr; 7(4):487-500. PubMed ID: 9052990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine transformation of hemopoietic cells resulting from cytokine message stabilization after intracisternal A particle transposition.
    Algate PA; McCubrey JA
    Oncogene; 1993 May; 8(5):1221-32. PubMed ID: 8479745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine transformation of human hematopoietic cells after transfection with an activated granulocyte/macrophage colony stimulating factor gene.
    Hoyle PE; Steelman LS; McCubrey JA
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):159-68. PubMed ID: 9426974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of an active form of the interleukin-2/15 receptor beta-chain by insertion of the intracisternal A particle in a radiation-induced mouse thymic lymphoma and its role in tumorigenesis.
    Ukai H; Ishii-Oba H; Ukai-Tadenuma M; Ogiu T; Tsuji H
    Mol Carcinog; 2003 Jun; 37(2):110-9. PubMed ID: 12766910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal activation of cytokine gene expression by intracisternal type A particle transposition: effects of mutations that result in autocrine growth stimulation and malignant transformation.
    Wang XY; Steelman LS; McCubrey JA
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):3-19. PubMed ID: 9287239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA.
    Wang E; Ma WJ; Aghajanian C; Spriggs DR
    Cancer Res; 1997 Dec; 57(23):5426-33. PubMed ID: 9393771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs.
    Fan H; Villegas C; Huang A; Wright JA
    Cancer Res; 1996 Oct; 56(19):4366-9. PubMed ID: 8813126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrotransposons as mutagens in the induction of growth autonomy in hematopoietic cells.
    Heberlein C; Kawai M; Franz MJ; Beck-Engeser G; Daniel CP; Ostertag W; Stocking C
    Oncogene; 1990 Dec; 5(12):1799-807. PubMed ID: 2178239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 3' untranslated region of prohibitin and cellular immortalization.
    Jupe ER; Liu XT; Kiehlbauch JL; McClung JK; Dell'Orco RT
    Exp Cell Res; 1996 Apr; 224(1):128-35. PubMed ID: 8612677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1 beta (IL-1 beta) in human fibroblasts and BC-8701 breast cancer cells.
    Rutter JL; Benbow U; Coon CI; Brinckerhoff CE
    J Cell Biochem; 1997 Sep; 66(3):322-36. PubMed ID: 9257189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between AUUUA motif disruption and enhancer insertion results in autocrine transformation of interleukin-3-dependent hematopoietic cells.
    Mayo MW; Wang XY; Algate PA; Arana GF; Hoyle PE; Steelman LS; McCubrey JA
    Blood; 1995 Oct; 86(8):3139-50. PubMed ID: 7579409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. V-Ha-ras-dependent expression of interleukin-3 mRNA in premalignant PB-3c mast cells correlates with the formation of tumors without interleukin-3 gene rearrangements.
    Aebersold DM; Banholzer R; Backenstoss V; Hirsch HH; Moroni C
    Exp Hematol; 1997 May; 25(5):395-404. PubMed ID: 9168061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
    Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
    Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the transforming activity of a truncated Int6 gene, in vitro.
    Rasmussen SB; Kordon E; Callahan R; Smith GH
    Oncogene; 2001 Aug; 20(38):5291-301. PubMed ID: 11536042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards endothelial-cell-directed cancer immunotherapy: in vitro expression of human recombinant cytokine genes by human and mouse primary endothelial cells.
    Ojeifo JO; Su N; Ryan US; Verma UN; Mazumder A; Zwiebel JA
    Cytokines Mol Ther; 1996 Jun; 2(2):89-101. PubMed ID: 9384693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
    Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
    Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrogation of factor-dependence in two IL-3-dependent cell lines can occur by two distinct mechanisms.
    McCubrey J; Holland G; McKearn J; Risser R
    Oncogene Res; 1989; 4(2):97-109. PubMed ID: 2785667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA.
    Stoecklin G; Gross B; Ming XF; Moroni C
    Oncogene; 2003 Jun; 22(23):3554-61. PubMed ID: 12789264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.